Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA-ALS Open Label Extension
NCT05753852Phase 3Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Oct 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of tauroursodeoxycholic acid in amyotrophic lateral sclerosis (ALS), sponsored by Humanitas Research Hospital. Status: unknown.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05753852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753852.